CombiGene Balance Sheet Health
Financial Health criteria checks 6/6
CombiGene has a total shareholder equity of SEK85.7M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK91.2M and SEK5.4M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 76.69m |
| Equity | SEK 85.74m |
| Total liabilities | SEK 5.45m |
| Total assets | SEK 91.18m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: COJ0's short term assets (SEK77.8M) exceed its short term liabilities (SEK5.4M).
Long Term Liabilities: COJ0's short term assets (SEK77.8M) exceed its long term liabilities (SEK1,000.0).
Debt to Equity History and Analysis
Debt Level: COJ0 is debt free.
Reducing Debt: COJ0 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: COJ0 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: COJ0 has sufficient cash runway for 2.4 years if free cash flow continues to reduce at historical rates of 3.5% each year.